Hong Wang Selected Research

Cardiogenic Shock

1/2022	Percutaneous versus surgical cannulation for femoro-femoral VA-ECMO in patients with cardiogenic shock: Results from the Extracorporeal Life Support Organization Registry.
1/2022	Intra-aortic balloon pump impacts the regional haemodynamics of patients with cardiogenic shock treated with femoro-femoral veno-arterial extracorporeal membrane oxygenation.
1/2022	Quality of Life and Mid-Term Survival in Patients Receiving Extracorporeal Membrane Oxygenation After Cardiac Surgery.
1/2021	Disseminated Intravascular Coagulation Score Is Related to Short-term Mortality in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation After Cardiac Surgery.
1/2021	Neurologic Complications in Adult Post-cardiotomy Cardiogenic Shock Patients Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Cohort Study.
1/2021	The Relative Early Decrease in Platelet Count Is Associated With Mortality in Post-cardiotomy Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
1/2021	Drainage From Superior Vena Cava Improves Upper Body Oxygenation in Patients on Femoral Veno-Arterial Extracorporeal Membrane Oxygenation.
11/2020	Survival following venoarterial extracorporeal membrane oxygenation in postcardiotomy cardiogenic shock adults.
1/2020	Risk factors of in-hospital mortality in adult postcardiotomy cardiogenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation.
11/2019	The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Postcardiotomy Patients with Cardiogenic Shock: A Pilot Randomized Controlled Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Wang Research Topics

Disease

497	Neoplasms (Cancer) 10/2022 - 01/2001
181	Inflammation (Inflammations) 06/2022 - 04/2002
124	Infections 09/2022 - 01/2002
74	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 05/2003
72	Breast Neoplasms (Breast Cancer) 07/2022 - 10/2002
67	Neoplasm Metastasis (Metastasis) 11/2021 - 06/2004
57	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 09/2004
55	Lung Neoplasms (Lung Cancer) 10/2022 - 09/2003
48	Hypoxia (Hypoxemia) 01/2022 - 02/2003
47	Atherosclerosis 06/2022 - 05/2003
45	Carcinogenesis 07/2022 - 03/2006
43	Insulin Resistance 01/2022 - 09/2003
42	Obesity 08/2022 - 09/2003
39	Fibrosis (Cirrhosis) 06/2022 - 10/2005
37	Body Weight (Weight, Body) 01/2022 - 01/2009
34	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 10/2006
33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 05/2012
33	Pain (Aches) 03/2022 - 03/2002
32	Stroke (Strokes) 06/2022 - 11/2004
32	Adenocarcinoma of Lung 05/2022 - 09/2002
32	Myocardial Infarction 01/2022 - 07/2006
31	Sepsis (Septicemia) 03/2022 - 01/2003
31	Type 2 Diabetes Mellitus (MODY) 10/2021 - 09/2003
29	Ischemia 06/2022 - 11/2007
28	Wounds and Injuries (Trauma) 09/2022 - 06/2002
28	Hypertension (High Blood Pressure) 01/2022 - 12/2002
27	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 06/2004
25	Thrombosis (Thrombus) 09/2022 - 04/2005
24	Melanoma (Melanoma, Malignant) 01/2022 - 01/2007
24	Hyperlipidemias (Hyperlipidemia) 06/2021 - 11/2009
23	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 04/2011
22	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 12/2004
22	Adenocarcinoma 01/2022 - 11/2003
21	Hemorrhage 09/2022 - 02/2002
20	Ischemic Stroke 12/2022 - 01/2008
19	Pneumococcal Infections 01/2019 - 03/2010
18	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 06/2007
18	Coronary Artery Disease (Coronary Atherosclerosis) 04/2021 - 06/2004
17	Cardiogenic Shock 01/2022 - 04/2014
17	Leukemia 09/2021 - 01/2001
17	Pulmonary Hypertension 05/2021 - 02/2003
17	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 08/2004
16	Reperfusion Injury 12/2022 - 08/2005
16	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2013
16	Virus Diseases (Viral Diseases) 01/2022 - 10/2007
16	Liver Diseases (Liver Disease) 12/2021 - 10/2012

Drug/Important Bio-Agent (IBA)

258	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2002
97	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2002
93	CytokinesIBA 06/2022 - 01/2003
84	Pharmaceutical PreparationsIBA 09/2022 - 01/2001
66	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2010
56	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 12/2003
52	Messenger RNA (mRNA)IBA 03/2022 - 01/2002
48	Biological ProductsIBA 09/2022 - 10/2002
46	EnzymesIBA 05/2022 - 01/2001
44	LipidsIBA 01/2022 - 07/2005
43	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 09/2003
33	Long Noncoding RNAIBA 07/2022 - 09/2014
32	Therapeutic UsesIBA 09/2022 - 06/2004
32	Interleukin-6 (Interleukin 6)IBA 02/2022 - 03/2008
31	Insulin (Novolin)FDA Link 01/2022 - 09/2003
30	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022 - 04/2006
29	RNA (Ribonucleic Acid)IBA 05/2022 - 12/2003
29	LigandsIBA 01/2022 - 05/2002
28	VaccinesIBA 07/2022 - 11/2006
27	Peptides (Polypeptides)IBA 06/2022 - 01/2004
27	AntigensIBA 06/2021 - 11/2003
25	InflammasomesIBA 12/2022 - 01/2013
23	Oxygen (Dioxygen)IBA 10/2021 - 10/2003
22	LipopolysaccharidesIBA 05/2022 - 08/2006
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2022 - 01/2004
22	AntioxidantsIBA 01/2022 - 05/2009
22	Transcription Factors (Transcription Factor)IBA 12/2021 - 06/2003
21	Polysaccharides (Glycans)IBA 08/2022 - 03/2010
21	Small Interfering RNA (siRNA)IBA 12/2020 - 02/2009
20	Circular RNAIBA 07/2022 - 01/2017
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 05/2005
19	AntibodiesIBA 01/2022 - 01/2002
18	Indicators and Reagents (Reagents)IBA 06/2022 - 12/2003
18	InterferonsIBA 01/2022 - 03/2007
18	oxidized low density lipoproteinIBA 01/2022 - 05/2003
18	CholesterolIBA 01/2022 - 05/2003
18	ProteomeIBA 12/2021 - 08/2002
18	Caspase 3 (Caspase-3)IBA 12/2020 - 01/2002
17	Blood Glucose (Blood Sugar)IBA 08/2022 - 07/2005
17	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2003
16	CalciumIBA 02/2022 - 02/2007
16	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2006
16	HomocysteineIBA 01/2022 - 05/2003
16	CollagenIBA 12/2021 - 08/2004

Therapy/Procedure

256	Therapeutics 09/2022 - 01/2001
54	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
32	Transplantation 06/2022 - 02/2009
25	Immunotherapy 10/2022 - 11/2006
25	Aftercare (After-Treatment) 02/2022 - 02/2002
23	Extracorporeal Membrane Oxygenation 01/2022 - 04/2014
20	Lasers (Laser) 09/2022 - 05/2003
17	Ligation 06/2022 - 11/2007
17	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2022 - 04/2002
17	Radiotherapy 06/2021 - 11/2004